These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 33329406)

  • 1. miRNA-Mediated Immune Regulation in Islet Autoimmunity and Type 1 Diabetes.
    Scherm MG; Daniel C
    Front Endocrinol (Lausanne); 2020; 11():606322. PubMed ID: 33329406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of T cell miRNAs for regulatory T cell induction in islet autoimmunity.
    Scherm MG; Serr I; Kaestner KH; Daniel C
    Mol Metab; 2019 Sep; 27S(Suppl):S122-S128. PubMed ID: 31500823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miRNA Regulation of T Cells in Islet Autoimmunity and Type 1 Diabetes.
    Scherm MG; Daniel C
    Curr Diab Rep; 2020 Jul; 20(9):41. PubMed ID: 32725277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miRNA142-3p targets Tet2 and impairs Treg differentiation and stability in models of type 1 diabetes.
    Scherm MG; Serr I; Zahm AM; Schug J; Bellusci S; Manfredini R; Salb VK; Gerlach K; Weigmann B; Ziegler AG; Kaestner KH; Daniel C
    Nat Commun; 2019 Dec; 10(1):5697. PubMed ID: 31836704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miRNA92a targets KLF2 and the phosphatase PTEN signaling to promote human T follicular helper precursors in T1D islet autoimmunity.
    Serr I; Fürst RW; Ott VB; Scherm MG; Nikolaev A; Gökmen F; Kälin S; Zillmer S; Bunk M; Weigmann B; Kunschke N; Loretz B; Lehr CM; Kirchner B; Haase B; Pfaffl M; Waisman A; Willis RA; Ziegler AG; Daniel C
    Proc Natl Acad Sci U S A; 2016 Oct; 113(43):E6659-E6668. PubMed ID: 27791035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KLRG1 expression identifies short-lived Foxp3
    Kornete M; Mason E; Istomine R; Piccirillo CA
    Autoimmunity; 2017 Sep; 50(6):354-362. PubMed ID: 28850267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancreatic islet autoimmunity.
    Boitard C
    Presse Med; 2012 Dec; 41(12 P 2):e636-50. PubMed ID: 23182678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging Therapeutic Strategies to Restore Regulatory T Cell Control of Islet Autoimmunity in Type 1 Diabetes.
    Volfson-Sedletsky V; Jones A; Hernandez-Escalante J; Dooms H
    Front Immunol; 2021; 12():635767. PubMed ID: 33815387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tolerogenic Nanoparticles to Treat Islet Autoimmunity.
    Neef T; Miller SD
    Curr Diab Rep; 2017 Aug; 17(10):84. PubMed ID: 28791576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Common patterns of gene regulation associated with Cesarean section and the development of islet autoimmunity - indications of immune cell activation.
    Laimighofer M; Lickert R; Fuerst R; Theis FJ; Winkler C; Bonifacio E; Ziegler AG; Krumsiek J
    Sci Rep; 2019 Apr; 9(1):6250. PubMed ID: 31000755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of serum microRNAs with islet autoimmunity, disease progression and metabolic impairment in relatives at risk of type 1 diabetes.
    Snowhite IV; Allende G; Sosenko J; Pastori RL; Messinger Cayetano S; Pugliese A
    Diabetologia; 2017 Aug; 60(8):1409-1422. PubMed ID: 28500393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunomodulation Followed by Antigen-Specific T
    Cabello-Kindelan C; Mackey S; Sands A; Rodriguez J; Vazquez C; Pugliese A; Bayer AL
    Diabetes; 2020 Feb; 69(2):215-227. PubMed ID: 31712320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunomodulatory properties of pancreatic islet-derived stem cells co-cultured with T cells: Does it contribute to the pathogenesis of type 1 diabetes?
    Sariboyaci AE; Demircan PC; Gacar G; Unal ZS; Erman G; Karaoz E
    Exp Clin Endocrinol Diabetes; 2014 Mar; 122(3):179-89. PubMed ID: 25014767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type 1 diabetes vaccine candidates promote human Foxp3(+)Treg induction in humanized mice.
    Serr I; Fürst RW; Achenbach P; Scherm MG; Gökmen F; Haupt F; Sedlmeier EM; Knopff A; Shultz L; Willis RA; Ziegler AG; Daniel C
    Nat Commun; 2016 Mar; 7():10991. PubMed ID: 26975663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miRNAs: novel regulators of autoimmunity-mediated pancreatic β-cell destruction in type 1 diabetes.
    Zheng Y; Wang Z; Zhou Z
    Cell Mol Immunol; 2017 Jun; 14(6):488-496. PubMed ID: 28317889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD8+ T cell tolerance in nonobese diabetic mice is restored by insulin-dependent diabetes resistance alleles.
    Martinez X; Kreuwel HT; Redmond WL; Trenney R; Hunter K; Rosen H; Sarvetnick N; Wicker LS; Sherman LA
    J Immunol; 2005 Aug; 175(3):1677-85. PubMed ID: 16034108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulatory roles of micro-RNAs in T cell autoimmunity.
    Esmailzadeh S; Mansoori B; Mohammadi A; Baradaran B
    Immunol Invest; 2017 Nov; 46(8):864-879. PubMed ID: 29058542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA signature of regulatory T cells in health and autoimmunity.
    Soltanzadeh-Yamchi M; Shahbazi M; Aslani S; Mohammadnia-Afrouzi M
    Biomed Pharmacother; 2018 Apr; 100():316-323. PubMed ID: 29453041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Logic and extent of miRNA-mediated control of autoimmune gene expression.
    Vinuesa CG; Rigby RJ; Yu D
    Int Rev Immunol; 2009; 28(3-4):112-38. PubMed ID: 19811318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Islet autoimmunity in phenotypic type 2 diabetes patients.
    Brooks-Worrell B; Narla R; Palmer JP
    Diabetes Obes Metab; 2013 Sep; 15 Suppl 3(0 3):137-40. PubMed ID: 24003930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.